HRP Portfolio Reviews
In 2008, the National Academies of Science, Engineering, and Medicine (formerly the Institute of Medicine (IOM)) began reviewing the HRP’s compilation of evidence on human health risks in spaceflight and NASA’s risk identification and management process. Selected Evidence Reports have been reviewed by the National Academy each year since 2008 such that a complete review of the HRP evidence base would occur approximately every 5 years.

The HRP Standing Review Panels (SRPs) were activated in 2009 with the purpose of reviewing the Integrated Research Plan (IRP) that outlines gaps, associated tasks and research deliverables for each risk in the HRP portfolio. Panel members include university faculty; NASA civil servants; non-NASA civil servants from the military, Department of Energy (DOE) and Centers for Disease Control and Prevention (CDC); and representatives from industry. These panels convene approximately once a year to provide updated recommendations to the HRP. From 2010 through 2015 the SRPs also reviewed new and updated Evidence Reports in the years between National Academy reviews.

A Research and Clinical Advisory Panel (RCAP) is used to review the evidence and research plan for the Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations (VIIP).


CURRENT REVIEWS

Reviews of HRP Evidence: Reviews of HRP Research Plans:
Archived Reviews